| 前收市價 | 33.21 |
| 開市 | 33.54 |
| 買盤 | 34.89 x 1000 |
| 賣出價 | 34.78 x 1000 |
| 今日波幅 | 33.47 - 35.57 |
| 52 週波幅 | 27.38 - 165.29 |
| 成交量 | |
| 平均成交量 | 8,142,882 |
| 市值 | 5.614B |
| Beta 值 (5 年，每月) | 0.81 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -43.42 |
| 業績公佈日 | 2022年7月25日 - 2022年7月29日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 57.66 |
- Insider Monkey
10 Cathie Wood Stocks That Can Rebound in 2023
In this article, we discuss 10 Cathie Wood stocks that can rebound in 2023. If you want to see more stocks in this selection, click 5 Cathie Wood Stocks That Can Rebound in 2023. Cathie Wood’s ARK Investment Management has admittedly been battered by the rising rates environment and the market-wide selloff in growth equities. […]
- InvestorPlace
7 Growth Stocks to Buy for a Bear Market
If you’re looking to make gains in a bear market, then you need to find the right growth stocks to buy. Intuitive Surgical (ISRG): Flagship da Vinci systems continue to gain traction with every passing quarter. Teladoc Health (TDOC): Membership base continues to rise at an aggressive pace despite the pandemic fade. CrowdStrike Holdings (CRWD): Recurring revenues and retention rates remain impressive and will continue driving robust growth. Globant SA (GLOB): Has a massive client base who are lik
- InvestorPlace
Legal Problems Could Push Teladoc Health Stock to New Lows
Based in New York, Teladoc Health (NYSE:TDOC) specializes in the niche market known as telemedicine or telehealth. Investors might feel optimistic overall about the telemedicine market, but there are too many company-specific problems going on to recommend TDOC stock. When the Covid-19 lockdowns occurred in 2020, Teladoc Health suddenly became a darling on Wall Street. The hype phase ran its course quickly, but for a while, investors were ultra-bullish on Teladoc. Fast-forward to mid-2022, and T
